News Recap: SolarEdge Technologies, Inc. (NASDAQ:SEDG), Editas Medicine Inc. (NASDAQ:EDIT)


SolarEdge Technologies, Inc. (NASDAQ:SEDG)

SolarEdge Technologies, Inc. (NASDAQ:SEDG) represented a move of 2.5 percent or $-1.05 per share and closed its previous day trading session at $36.9. 1.1 Million Shares were traded in the last trading session with an Average Volume of 699.17 Million Shares. The stock currently has a Market Capitalization of 1.59 Billion.

SolarEdge Technologies, Inc. provides inverter solution. The company’s SolarEdge system offers power optimizers, inverters and a cloud-based monitoring platform. It serves residential solar installations to commercial and small utility-scale solar installations. SolarEdge Technologies, Inc. is headquartered in Hod Hasharon, Israel.

The stock traded between $13.50 and $39.90 over 1-Year time period showing its price to sales ratio of 3. SolarEdge Technologies, Inc. (NASDAQ:SEDG) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $1.79 and 200-Day Simple Moving Average of $30.64. Its Price to Free Cash Flow is 0 and Price to Book of 4.24.

Analyst’s recommended the stock as 2.2 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, SolarEdge Technologies, Inc. (NASDAQ:SEDG) reported its Actual EPS of $0.85/share. The analysts offering Earnings Estimates for the company were believing that SolarEdge Technologies, Inc. could bring EPS of $0.65/share. The difference between Actual EPS and Estimated EPS was 0.2 Percent. Thus showing an Earnings Surprise of 30.8 Percent.

Editas Medicine Inc. (NASDAQ:EDIT)

In the last trading session, Editas Medicine Inc. (NASDAQ:EDIT) added its value by 4.5% closing at the price of $34.59. The stock currently has market capitalization of 1.51 Billion, with average volume of 1.54 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Editas Medicine Inc. (NASDAQ:EDIT) is showing beta of 0. This particular value of beta suggests that Editas Medicine Inc. (NASDAQ:EDIT) has historically moved 0% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Editas Medicine Inc. (NASDAQ:EDIT) is at $-3.25.

The stock currently has RSI of 54.41. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Editas Medicine, Inc. is a genome editing company. It focuses on translating its genome editing technology into a novel class of human therapeutics which enable precise and corrective molecular modification to treat diseases. Editas Medicine, Inc. is based in Cambridge, Massachusetts.

Editas Medicine Inc. (NASDAQ:EDIT) topped its 52-week high price of $41.60 on 01/29/18 and 52-Week Low Price of $13.12 on 05/31/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 10.01% and monthly volatility of 9.07% respectively.